Neumora Therapeutics Inc.... (NMRA)
NASDAQ: NMRA
· Real-Time Price · USD
1.62
0.04 (2.53%)
At close: Aug 15, 2025, 3:59 PM
1.66
2.47%
After-hours: Aug 15, 2025, 07:51 PM EDT
Neumora Therapeutics Common Stock Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -52.73M | -67.99M | -58.82M | -72.55M | -58.7M | -53.72M | -108.73M | -53.03M | -38.54M | -35.63M | -28.15M | -29.34M | -30.37M | -43.04M | -26.97M | -178.03M | -17.01M | -15.3M |
Depreciation & Amortization | 19K | 157K | 157K | 156K | 160K | 158K | 166K | 173K | 171K | 158K | 147K | 146K | 154K | 147K | 131K | 150K | 125K | 132K |
Stock-Based Compensation | 7.17M | 9.32M | 9.9M | 9.95M | 12.77M | 7.37M | 6.05M | 6.45M | 2.54M | 2.19M | 2.79M | 2.1M | 1.75M | 1.65M | 1.22M | 1.19M | 1.06M | 810K |
Other Working Capital | n/a | 1.73M | 1.54M | 417K | -8.62M | 2.44M | -11.2M | -1.5M | -1.94M | 6.32M | -2.07M | -47K | 456K | -4.04M | -3.61M | 2.49M | 1.87M | -949K |
Other Non-Cash Items | -6.86M | n/a | -225K | 23.52M | -1.35M | 791K | 64.86M | 859K | 850K | 814K | 799K | 1.03M | 302K | 13.22M | 750K | 157.18M | 73K | 42K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -673K | -1.04M | n/a | n/a | -781K | -250K | -145K | -109K | -53K | 316K | -198K | -118K |
Change in Working Capital | n/a | -525K | -1.36M | 5.44M | -9.03M | 3.59M | -13.11M | -1.19M | 5.1M | 309K | -5.18M | 555K | 1.73M | -4.06M | -4.48M | 2.25M | 2.19M | -924K |
Operating Cash Flow | -52.4M | -59.45M | -50.34M | -33.48M | -56.16M | -42.95M | -51.44M | -47.77M | -31.02M | -33.04M | -30.37M | -25.76M | -26.58M | -32.19M | -29.35M | -17.26M | -13.57M | -15.24M |
Capital Expenditures | n/a | n/a | n/a | 775K | n/a | -775K | -44K | -37K | n/a | -36K | -23K | -130K | -182K | -176K | -188K | -217K | -139K | -273K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 300K |
Purchase of Investments | -39.38M | -45.67M | -106.9M | 16K | -19.54M | -185.8M | -20.07M | -12.86M | -34.66M | -41.48M | -48.09M | -12.48M | -93.36M | -72.43M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 68.8M | 88.55M | 8.1M | 156.97M | 40.79M | 36.58M | 38.38M | 36.71M | 58.74M | 44.34M | 40.09M | 29.3M | 2.48M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 980K | 1.29M | n/a | -775K | n/a | -775K | -4.59M | n/a | n/a | n/a | n/a | n/a | 2.48M | -13M | n/a | -330K | 30K | 300K |
Investing Cash Flow | 30.4M | 44.16M | -98.8M | 156.99M | 21.25M | -150M | 13.68M | 23.82M | 24.08M | 2.82M | -8.03M | 16.69M | -91.07M | -85.61M | -188K | -547K | -109K | 27K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -491K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 18.46M | n/a | 1.88M | 1.53M | 2.65M | 1.84M | -481K | 232.02M | 292K | 101K | 1.86M | 87.18M | 2.08M | -351K | -295K | 291.99M | 640K | 280K |
Financial Cash Flow | 18.46M | n/a | 15.57M | 1.53M | 2.65M | 1.84M | -481K | 232.02M | 292K | 101K | 26.83M | 87.18M | 2.08M | -351K | -358K | 291.99M | 640K | 1.24M |
Net Cash Flow | -3.55M | -15.29M | -133.57M | 126.25M | -32.25M | -191.11M | -38.25M | 208.07M | -6.65M | -30.12M | -11.56M | 78.11M | -115.57M | -118.14M | -29.9M | 274.18M | -13.04M | -13.98M |
Free Cash Flow | -52.4M | -59.45M | -50.34M | -32.71M | -56.16M | -43.73M | -51.49M | -47.81M | -31.02M | -33.08M | -30.39M | -25.89M | -26.76M | -32.36M | -29.54M | -17.47M | -13.71M | -15.52M |